KVUE Kenvue Inc.

$21.10

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Kenvue, Inc. (KVUE) is poised to capture investor attention as it approaches its earnings announcement on July 17, 2025, with a market cap of over $40 billion underscoring its significant presence in the industry. Analysts are eyeing an EPS estimate of $0.28, while the whisper number suggests a slightly more optimistic outlook at $0.30, indicating a potential upside surprise. The revenue estimate stands at $3.94 billion, reflecting the company's robust market position and strategic initiatives aimed at sustaining growth. Despite the absence of recent news, Kenvue's consistent performance and strategic focus on innovation and market expansion are likely to be key themes in the upcoming earnings call. Investors will be keen to see if Kenvue can exceed expectations and align with the whisper number, which could further bolster market confidence in its growth trajectory.

Updated On 8/18/2025

About Kenvue Inc.

Kenvue Inc. is a consumer health company globally.

Website: https://www.kenvue.com

Sector
LIFE SCIENCES
Industry
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1944048
Address
199 GRANDVIEW ROAD, SKILLMAN, NJ, UNITED STATES
Valuation
Market Cap
$44.88B
P/E Ratio
43.31
PEG Ratio
2.39
Price to Book
4.64
Performance
EPS
$0.54
Dividend Yield
3.51%
Profit Margin
6.67%
ROE
9.87%
Technicals
50D MA
$22.76
200D MA
$21.91
52W High
$24.36
52W Low
$17.18
Fundamentals
Shares Outstanding
2B
Target Price
$24.21
Beta
nan

KVUE EPS Estimates vs Actual

Estimated
Actual

KVUE News & Sentiment

Aug 12, 2025 • Motley Fool SOMEWHAT-BULLISH
Johnson & Johnson EVP Sells JNJ Shares Worth $3 Million
John C. Reed, Executive Vice President, Innovative Medicine and R&D of Johnson & Johnson ( NYSE:JNJ ) , executed an open market sale of 19,137 shares as disclosed in a Form 4 filed July 18, 2025.How does this transaction compare to John C.
Aug 12, 2025 • Motley Fool SOMEWHAT-BULLISH
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Dip into a beaten-down market sector for deals on some proven winners.
Aug 07, 2025 • Motley Fool NEUTRAL
Kenvue ( KVUE ) Q2 Sales Drop 4%
Kenvue ( NYSE:KVUE ) , the consumer health company best known for brands like Tylenol and Band-Aid, reported its earnings for the second quarter on August 7, 2025. The main news from the release: Non-GAAP earnings per share reached $0.29, narrowly beating analyst forecasts of $0.28 ( non-GAAP ) , ...
Aug 07, 2025 • Zacks Commentary NEUTRAL
Kenvue ( KVUE ) Q2 Earnings Top Estimates
Kenvue (KVUE) delivered earnings and revenue surprises of +3.57% and -0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 05, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Edgewell Personal Care ( EPC ) Misses Q3 Earnings and Revenue Estimates
Edgewell Personal (EPC) delivered earnings and revenue surprises of -8.91% and -4.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 04, 2025 • Zacks Commentary NEUTRAL
Countdown to Kenvue ( KVUE ) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Kenvue (KVUE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Sentiment Snapshot

Average Sentiment Score:

0.182
50 articles with scored sentiment

Overall Sentiment:

Bullish

KVUE Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Feb 06, 2025
Dec 31, 2024 (Pre market)
-0.05 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.31
  • Whisper:
  • Surprise %: -16.1%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.27
  • Whisper:
  • Surprise %: 3.7%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 14.3%
May 07, 2024
Mar 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.26
  • Whisper:
  • Surprise %: 7.7%
Feb 08, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.31
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 10.7%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.31
  • Estimate: $0.31
  • Whisper:
  • Surprise %: 0.0%
Jul 20, 2023
Jun 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.30
  • Whisper:
  • Surprise %: 6.7%
Jun 02, 2023
Mar 31, 2023 (Post market)
-0.13 Surprise
  • Reported EPS: $0.19
  • Estimate: $0.32
  • Whisper:
  • Surprise %: -40.6%

Financials